During the past decade, Gitte Dam conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gitte Dam" are "Hepatic Encephalopathy" (1 trials), "Liver Cirrhosis" (1 trials) and "Neuroendocrine Tumors (NET) Health Related Qualito of Life (HRQoL)" (1 trials). Many other conditions were trialed in "Gitte Dam" in a lesser frequency.

Most popular intervention types in "Gitte Dam" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Somatostatin analog" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gitte Dam" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Gitte Dam". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Gitte Dam, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gitte Dam, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".